Federal Register Final rule: FDA is amending the standing advisory committees’ regulations to change the name of the Anti-Infective Drugs Advisory Committee to the Antimicrobial Drugs Advisory Committee to better reflect the products and issues that will be brought to the committee. This action is being taken to change the name of this committee on the agency’s list of standing advisory committees. To view this notice, click here.